Sagimet Biosciences Cash Flow Statement (2022-2026) | SGMT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -7.10M-7.47M-7.20M-6.58M-6.79M-6.36M-8.15M-6.63M-8.12M-14.62M-16.20M-18.18M-10.39M-12.91M-9.57M-10.65M
Share-based Compensation (Quarter) 0.38M0.39M0.72M0.77M1.06M1.85M1.31M0.76M1.45M1.55M1.53M1.47M1.60M1.69M1.69M1.84M
Gains from Sales and Divestitures (Quarter) 0.28M0.28M0.28M0.28M0.06M
Gains from Investment Securities (Quarter) -0.00M3.78M-0.00M-0.10M0.04M1.15M4.32M147.00147.001.28M-0.05M0.72M
Non-cash Items (Quarter) 4.00M1.67M1.78M0.01M2.27M10.30M9.50M0.62M2.74M3.14M3.42M3.80M4.00M
Cash from Operations (Quarter) -0.00M-6.20M-7.49M-7.08M-5.72M-3.88M-7.08M-6.21M-5.63M-19.57M-11.02M-14.54M-9.10M-10.18M-11.83M-8.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.09M0.08M0.04M0.00M-0.00M0.19M0.48M0.53M0.06M0.54M0.23M-0.07M-0.30M0.14M
Change in Working Capital
Change in Accured Expenses (Quarter) 1.05M-1.00M-1.19M-0.40M1.39M0.32M-0.78M1.09M-1.66M0.44M3.39M-0.05M1.56M-3.97M0.64M
Investing Activities
Change in Acquisitions & Divestments (Quarter) 5.44M19.40M12.80M3.00M7.79M12.00M23.61M18.99M29.66M31.34M31.43M16.97M
Cash from Investing Activities (Quarter) 4.00M5.44M19.40M12.80M-19.62M3.00M-75.16M0.62M9.85M3.41M-13.29M0.07M14.36M10.22M
Financing Activities
Other financing activities (Quarter) 0.06M0.14M0.91M1.02M0.03M0.00M
Change in Capital Stock
Shares Issued (Quarter) 0.01M0.10M0.01M0.30M-0.03M
Misc.
Cash from Financing Activities (Quarter) -0.06M-0.14M-0.91M87.21M104.85M-0.03M0.27M
Change in Cash (Quarter) -2.23M156.19M12.18M6.17M83.33M-99.81M101.64M-80.82M
Free Cash Flow (Quarter) -0.00M-6.20M-7.49M-7.08M-5.72M-3.88M-7.08M-6.21M-5.63M-19.57M-11.02M-14.54M-9.10M-10.18M-11.83M-8.61M
Net Cash Flow (Quarter) -0.00M-2.20M-2.11M12.18M6.17M83.33M-26.70M101.64M-80.82M-18.95M-1.17M-11.12M-22.39M-9.83M2.52M1.60M